Advanced glycation end products (AGEs) in relation to atherosclerotic lipid profiles in middle-aged and elderly diabetic patients

Lipids Health Dis. 2011 Dec 6:10:228. doi: 10.1186/1476-511X-10-228.

Abstract

Objectives: To evaluate the association between AGEs and atherosclerotic lipid profiles among aging diabetic patients in Taiwan.

Design and methods: After age and gender matching, we selected 207 diabetic subjects and 174 diabetic subjects with proteinuria. Lipid profiles, including total cholesterol (TC), triglycerides (TG), high density cholesterol-lipoprotein (HDL-C) and low density lipoprotein-cholesterol (LDL-C) were measured using standard methods. AGEs were measured with the immunoassay method.

Results: In general, males were heavier; however, females had higher AGEs, fasting glucose (GLU), TC, HDL-C and LDL-C levels than males, and had higher TC/HDL-C, LDL-C/HDL-C, and TG/HDL-C ratios compared to males. AGEs were more strongly correlated with TG levels and TCL/LDL-C, LDL-C/HDL-C and TG/HDL-C ratios when compared to glucose or hemoglobin A1c. Subjects had higher AGEs levels (≧ 2.0 AU) with more adverse lipid profiles.

Conclusion: AGEs seem to be a good biomarker to evaluate the association between diabetes and atherosclerotic disorders in aging diabetes.

MeSH terms

  • Aged
  • Atherosclerosis / blood*
  • Atherosclerosis / etiology
  • Blood Glucose / metabolism
  • Diabetes Mellitus, Type 2 / blood*
  • Diabetes Mellitus, Type 2 / complications
  • Female
  • Glycated Hemoglobin / metabolism
  • Glycation End Products, Advanced / blood*
  • Humans
  • Lipids / blood*
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Regression Analysis
  • Statistics, Nonparametric

Substances

  • Blood Glucose
  • Glycated Hemoglobin A
  • Glycation End Products, Advanced
  • Lipids
  • hemoglobin A1c protein, human